This analysis confirmed the significant correlation between FP status and larger tumour size in our xenografts (R=0.73, P=0.04), as well as the correlation of VEGFA secretion and neo-vessel induction sensitivity upon regorafenib treatment. Here, VEGFA is linked to neoplasm.